Dialysing the Elderly Patient with Congestive Heart Failure: What Is Important to Know?

  • Andrew DavenportEmail author


The number of elderly patients surviving with increasing and more complex co-morbidity, especially in affluent countries, continues to grow exponentially. Elderly patients with the combination of chronic kidney disease stage 5 and congestive heart failure (CHF) have an increased risk of death. They should, if possible, be empowered to choose between conservative supportive care and dialysis. In countries without well-developed supportive palliative care programs, greater numbers of elderly patients with high co-morbidity scores, including CHF, withdraw from dialysis within the first few months of starting treatment [1]. This is particularly true for haemodialysis (HD). It is worth noting that a 4 h HD session may well expand into 8–10 h day, with the patient feeling too exhausted to do anything but to simply go to straight to bed on final arrival at home [2].


Haemodialysis Peritoneal dialysis Heart failure Conservative management 


  1. 1.
    Chan HW, Clayton PA, McDonald SP, Agar JW, Jose MD (2012) Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008. Clin J Am Soc Nephrol 7(5):775–781CrossRefPubMedGoogle Scholar
  2. 2.
    Carson RC, Juszczak M, Davenport A, Burns A (2009) Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4(10):1611–1619CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC (2012) Eur Heart J 33:1787–1847Google Scholar
  4. 4.
    USRDS annual data report: atlas of chronic kidney disease and end-stage renal disease in the US National Institutes of Health, Diabetes and Digestive and Kidney Diseases 2007, BethesdaGoogle Scholar
  5. 5.
    Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G (2006) Characteristics of sudden death in haemodialysis patients. Kidney Int 69:2268–2273CrossRefPubMedGoogle Scholar
  6. 6.
    CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435CrossRefGoogle Scholar
  7. 7.
    The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302CrossRefGoogle Scholar
  8. 8.
    Matsumoto Y, Kageyama S, Yakushigawa T, Arihara K, Sugiyama T, Mori Y, Sugiyama H, Ohmura H, Shio N (2009) Long-term low-dose spironolactone therapy is safe in oligoanuric haemodialysis patients. Cardiology 114(1):32–38CrossRefPubMedGoogle Scholar
  9. 9.
    Asif A, Salman LH, Lopera GG, Carrillo RG (2011) The dilemma of transvenous cardiac rhythm devices in haemodialysis patients: time to consider the epicardial approach? Kidney Int 79(12):1267–1269CrossRefPubMedGoogle Scholar
  10. 10.
    Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK (2011) Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 6(11):2662–2668CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Chan KE, Lazarus JM, Thadhani R, Hakim RM (2009) Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20(10):2223–2233CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lip GY, Piotrponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, Morais J, Pullicino P, Rasmussen LH, Marín F, Lane DA (2012) Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC working group on thrombosis. Thromb Haemost 108(6):1009–1022CrossRefPubMedGoogle Scholar
  13. 13.
    Pamukcu B, Lip GY, Lane DA (2010) Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores. Age Ageing 39(5):533–535CrossRefPubMedGoogle Scholar
  14. 14.
    Fehrman-Ekholm I, Lotsander A, Logan K, Dunge D, Odar-Cederlöf I, Kallner A (2008) Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with haemodialysis and on-line haemodiafiltration or haemofiltration. Scand J Urol Nephrol 42:74–80CrossRefPubMedGoogle Scholar
  15. 15.
    Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R, Magdeleyns EJ, Herfs M, Vermeer C, Laverman GD (2012) Vitamin K intake and status are low in haemodialysis patients. Kidney Int 82(5):605–610CrossRefPubMedGoogle Scholar
  16. 16.
    McKeag NA, McKinley MC, Woodside JV, Harbinson MT, McKeown PP (2012) The role of micronutrients in heart failure. J Acad Nutr Diet 112(6):870–886CrossRefPubMedGoogle Scholar
  17. 17.
    Sandek A, Bjarnason I, Volk HD, Crane R, Meddings JB, Niebauer J, Kalra PR, Buhner S, Herrmann R, Springer J, Doehner W, von Haehling S, Anker SD, Rauchhaus M (2012) Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int J Cardiol 157(1):80–85CrossRefPubMedGoogle Scholar
  18. 18.
    Van Der Sande FM, Cnossen TT, Cornelis T, Konings CJ, Kooman JP, Leunissen KM (2012) Peritoneal dialysis in patients with heart failure. Minerva Urol Nefrol 64(3):163–172Google Scholar
  19. 19.
    Nakayama M (2013) Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective. Perit Dial Int 33(1):8–14CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Cnossen TT, Kooman JP, Krepel HP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM (2012) Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. Nephrol Dial Transplant 27(7):2794–2799CrossRefPubMedGoogle Scholar
  21. 21.
    Chou MT, Wang JJ, Sun YM, Sheu MJ, Chu CC, Weng SF, Chio CC, Kan WC, Chien CC (2012) Epidemiology and mortality among dialysis patients with acute coronary syndrome: Taiwan National Cohort Study. Int J Cardiol 167(6):2719–2723Google Scholar
  22. 22.
    Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK (2006) Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69(7):1222–1228CrossRefPubMedGoogle Scholar
  23. 23.
    Donauer J, Kölblin D, Bek M, Krause A, Böhler J (2000) Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects. Am J Kidney Dis 36(1):115–123CrossRefPubMedGoogle Scholar
  24. 24.
    Shah A, Davenport A (2012) Does a reduction in dialysate sodium improve blood pressure control in haemodialysis patients? Nephrology (Carlton) 17(4):358–363CrossRefGoogle Scholar
  25. 25.
    Santoro A, Mancini E, Gaggi R, Cavalcanti S, Severi S, Cagnoli L, Badiali F, Perrone B, London G, Fessy H, Mercadal L, Grandi F (2005) Electrophysiological response to dialysis: the role of dialysate potassium content and profiling. Contrib Nephrol 149:295–305CrossRefPubMedGoogle Scholar
  26. 26.
    Locatelli F, Covic A, Chazot C, Leunissen K, Luño J, Yaqoob M (2004) Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 19(4):785–796CrossRefPubMedGoogle Scholar
  27. 27.
    Selby NM, McIntyre CW (2006) A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 21(7):1883–1898CrossRefPubMedGoogle Scholar
  28. 28.
    Mancini E, Mambelli E, Irpinia M, Gabrielli D, Cascone C, Conte F, Meneghel G, Cavatorta F, Antonelli A, Villa G, Dal Canton A, Cagnoli L, Aucella F, Fiorini F, Gaggiotti E, Triolo G, Nuzzo V, Santoro A (2007) Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant 22(5):1420–1427CrossRefPubMedGoogle Scholar
  29. 29.
    Davenport A, Cox C, Thuraisingham R (2008) Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 73(6):759–764CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.UCL Center for Nephrology, University College London Medical School, Royal Free HospitalLondonUK

Personalised recommendations